JPP Call for Submissions: Special Issue on Adherence
Call for Submissions
Journal of Pediatric Psychology:
Special Issue on Adherence
Guest Editor: Lori J. Stark, Ph.D., ABPP
Due Date 11/01/12
“Drugs don’t work in patients who don’t take them!” Former U.S. Surgeon General C. Everett Koop.
Adherence is defined as “…the extent to which a person’s behavior -- taking medications, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider” (World Health Organization, 2003, pp. 3-4). Research with a wide range of chronic conditions in children and adolescents has indicated that nonadherence to treatment is pervasive (as high as 50% for some conditions). Nonadherence can take many forms including not filling prescriptions to skipping or missing doses and can be intentional (e.g., deciding not to take a medication because of side effects) or unintentional (e.g., forgetting). Poorer adherence has been documented for regimens that are more time-consuming and complex, and rates of nonadherence in pediatric chronic illness populations, especially among adolescents (Rapoff, 2010), are even higher than those in adult populations. Potentially serious health consequences can result from nonadherence. For example, incomplete adherence to immunosuppressive drugs has been linked to heart, kidney, and liver transplant failures (Ettemger et al. 1991). Nonadherence can influence clinical decisions about care, resulting in increases or changes in medication when none are needed. Nonadherence has been estimated to result in billions of dollars of excess medical care annually (The Task Force for Compliance, 1994). Despite the clinical importance of nonadherence and the significance of its impact on health care delivery, the assessment and treatment of adherence problems in pediatric chronic diseases have received surprisingly little attention (Rapoff, 2010). Moreover, few studies have evaluated the impact of interventions designed to promote adherence to medical treatment in childhood chronic diseases using randomized controlled trials (Rapoff, 2010).
The aim of this special issue is to highlight innovative approaches to the treatment or prevention of pediatric nonadherence. We anticipate studies will focus on a range of health conditions and topics including innovative approaches to assessing adherence and understanding causes of nonadherence. However, priority will be given to studies focused on interventions to improve adherence in pediatric health conditions and research examining the translation and dissemination of interventions previously demonstrated to be efficacious in clinical trials. In this regard, a broad range of research methodologies will be considered for the special issue, including single case or small-n designs, randomized clinical trials, qualitative methodologies, and demonstration studies. Regardless of topic or methodology, a premium will be placed on the manuscript’s demonstration of innovation. We expect manuscripts to highlight implications of the research for practitioners and/or policy makers.
Submissions for this special issue will be accepted until November 1, 2012.
Papers should be prepared in compliance with JPP’s Instructions to Authors (http://jpepsy.oxfordjournals.org/) and submitted through the ScholarOne Manuscript Central™ submission portal (http://mc.manuscriptcentral.com/jpepsy). Manuscripts will be peer reviewed.
Please direct all inquiries about the suitability of manuscripts for the special issue to Lori.Stark@CCHMC.org .